Clinical consequences of BRCA2 hypomorphism
Open Access
- 9 September 2021
- journal article
- case report
- Published by Springer Nature in npj Breast Cancer
- Vol. 7 (1) , 1-9
Abstract
The tumor suppressor FANCD1/BRCA2 is crucial for DNA homologous recombination repair (HRR). BRCA2 biallelic pathogenic variants result in a severe form of Fanconi anemia (FA) syndrome, whereas monoallelic pathogenic variants cause mainly hereditary breast and ovarian cancer predisposition. For decades, the co-occurrence in trans with a clearly pathogenic variant led to assume that the other allele was benign. However, here we show a patient with biallelic BRCA2 (c.1813dup and c.7796 A > G) diagnosed at age 33 with FA after a hypertoxic reaction to chemotherapy during breast cancer treatment. After DNA damage, patient cells displayed intermediate chromosome fragility, reduced survival, cell cycle defects, and significantly decreased RAD51 foci formation. With a newly developed cell-based flow cytometric assay, we measured single BRCA2 allele contributions to HRR, and found that expression of the missense allele in a BRCA2 KO cellular background partially recovered HRR activity. Our data suggest that a hypomorphic BRCA2 allele retaining 37–54% of normal HRR function can prevent FA clinical phenotype, but not the early onset of breast cancer and severe hypersensitivity to chemotherapy.Keywords
This publication has 38 references indexed in Scilit:
- Mutations in ERCC4, Encoding the DNA-Repair Endonuclease XPF, Cause Fanconi AnemiaThe American Journal of Human Genetics, 2013
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- Diagnosis of Fanconi Anemia: Chromosomal Breakage AnalysisAnemia, 2012
- A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell–based assayBlood, 2011
- Chromosome fragility in patients with Fanconi anaemia: diagnostic implications and clinical impactJournal of Medical Genetics, 2011
- Diagnosis of Fanconi anemia in patients with bone marrow failureHaematologica, 2009
- Studying Nonsense-Mediated mRNA Decay in Mammalian Cells2008
- A Systematic Genetic Assessment of 1,433 Sequence Variants of Unknown Clinical Significance in the BRCA1 and BRCA2 Breast Cancer–Predisposition GenesThe American Journal of Human Genetics, 2007
- Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2Journal of Medical Genetics, 2006
- Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathwayBlood, 2005